The gut microbiome and type 2 diabetes status in the Multiethnic Cohort.

<h4>Background</h4>The gut microbiome may play a role in inflammation associated with type 2 diabetes (T2D) development. This cross-sectional study examined its relation with glycemic status within a subset of the Multiethnic Cohort (MEC) and estimated the association of circulating bact...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gertraud Maskarinec, Phyllis Raquinio, Bruce S Kristal, Veronica W Setiawan, Lynne R Wilkens, Adrian A Franke, Unhee Lim, Loïc Le Marchand, Timothy W Randolph, Johanna W Lampe, Meredith A J Hullar
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5267dcdebb2e4c11a87671af2e458496
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5267dcdebb2e4c11a87671af2e458496
record_format dspace
spelling oai:doaj.org-article:5267dcdebb2e4c11a87671af2e4584962021-12-02T20:03:50ZThe gut microbiome and type 2 diabetes status in the Multiethnic Cohort.1932-620310.1371/journal.pone.0250855https://doaj.org/article/5267dcdebb2e4c11a87671af2e4584962021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0250855https://doaj.org/toc/1932-6203<h4>Background</h4>The gut microbiome may play a role in inflammation associated with type 2 diabetes (T2D) development. This cross-sectional study examined its relation with glycemic status within a subset of the Multiethnic Cohort (MEC) and estimated the association of circulating bacterial endotoxin (measured as plasma lipopolysaccharide-binding protein (LBP)) with T2D, which may be mediated by C-reactive protein (CRP).<h4>Methods</h4>In 2013-16, cohort members from five ethnic groups completed clinic visits, questionnaires, and stool and blood collections. Participants with self-reported T2D and/or taking medication were considered T2D cases. Those with fasting glucose >125 and 100-125 mg/dL were classified as undiagnosed (UT2D) and pre-diabetes (PT2D) cases, respectively. We characterized the gut microbiome through 16S rRNA gene sequencing and measured plasma LBP and CRP by standard assays. Linear regression was applied to estimate associations of the gut microbiome community structure and LBP with T2D status adjusting for relevant confounders.<h4>Results</h4>Among 1,702 participants (59.9-77.4 years), 735 (43%) were normoglycemic (NG), 506 (30%) PT2D, 154 (9%) UT2D, and 307 (18%) T2D. The Shannon diversity index decreased (ptrend = 0.05), while endotoxin, measured as LBP, increased (ptrend = 0.0003) from NG to T2D. Of 10 phyla, Actinobacteria (ptrend = 0.007), Firmicutes (ptrend = 0.003), and Synergistetes (ptrend = 0.02) were inversely associated and Lentisphaerae (ptrend = 0.01) was positively associated with T2D status. Clostridium sensu stricto 1, Lachnospira, and Peptostreptococcaceae were less, while Escherichia-Shigella and Lachnospiraceae were more abundant among T2D patients, but the associations with Actinobacteria, Clostridium sensu stricto 1, and Escherichia-Shigella may be due metformin use. PT2D/UT2D values were closer to NG than T2D. No indication was detected that CRP mediated the association of LBP with T2D.<h4>Conclusions</h4>T2D but not PT2D/UT2D status was associated with lower abundance of SCFA-producing genera and a higher abundance of gram-negative endotoxin-producing bacteria suggesting that the gut microbiome may contribute to chronic systemic inflammation and T2D through bacterial translocation.Gertraud MaskarinecPhyllis RaquinioBruce S KristalVeronica W SetiawanLynne R WilkensAdrian A FrankeUnhee LimLoïc Le MarchandTimothy W RandolphJohanna W LampeMeredith A J HullarPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 6, p e0250855 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Gertraud Maskarinec
Phyllis Raquinio
Bruce S Kristal
Veronica W Setiawan
Lynne R Wilkens
Adrian A Franke
Unhee Lim
Loïc Le Marchand
Timothy W Randolph
Johanna W Lampe
Meredith A J Hullar
The gut microbiome and type 2 diabetes status in the Multiethnic Cohort.
description <h4>Background</h4>The gut microbiome may play a role in inflammation associated with type 2 diabetes (T2D) development. This cross-sectional study examined its relation with glycemic status within a subset of the Multiethnic Cohort (MEC) and estimated the association of circulating bacterial endotoxin (measured as plasma lipopolysaccharide-binding protein (LBP)) with T2D, which may be mediated by C-reactive protein (CRP).<h4>Methods</h4>In 2013-16, cohort members from five ethnic groups completed clinic visits, questionnaires, and stool and blood collections. Participants with self-reported T2D and/or taking medication were considered T2D cases. Those with fasting glucose >125 and 100-125 mg/dL were classified as undiagnosed (UT2D) and pre-diabetes (PT2D) cases, respectively. We characterized the gut microbiome through 16S rRNA gene sequencing and measured plasma LBP and CRP by standard assays. Linear regression was applied to estimate associations of the gut microbiome community structure and LBP with T2D status adjusting for relevant confounders.<h4>Results</h4>Among 1,702 participants (59.9-77.4 years), 735 (43%) were normoglycemic (NG), 506 (30%) PT2D, 154 (9%) UT2D, and 307 (18%) T2D. The Shannon diversity index decreased (ptrend = 0.05), while endotoxin, measured as LBP, increased (ptrend = 0.0003) from NG to T2D. Of 10 phyla, Actinobacteria (ptrend = 0.007), Firmicutes (ptrend = 0.003), and Synergistetes (ptrend = 0.02) were inversely associated and Lentisphaerae (ptrend = 0.01) was positively associated with T2D status. Clostridium sensu stricto 1, Lachnospira, and Peptostreptococcaceae were less, while Escherichia-Shigella and Lachnospiraceae were more abundant among T2D patients, but the associations with Actinobacteria, Clostridium sensu stricto 1, and Escherichia-Shigella may be due metformin use. PT2D/UT2D values were closer to NG than T2D. No indication was detected that CRP mediated the association of LBP with T2D.<h4>Conclusions</h4>T2D but not PT2D/UT2D status was associated with lower abundance of SCFA-producing genera and a higher abundance of gram-negative endotoxin-producing bacteria suggesting that the gut microbiome may contribute to chronic systemic inflammation and T2D through bacterial translocation.
format article
author Gertraud Maskarinec
Phyllis Raquinio
Bruce S Kristal
Veronica W Setiawan
Lynne R Wilkens
Adrian A Franke
Unhee Lim
Loïc Le Marchand
Timothy W Randolph
Johanna W Lampe
Meredith A J Hullar
author_facet Gertraud Maskarinec
Phyllis Raquinio
Bruce S Kristal
Veronica W Setiawan
Lynne R Wilkens
Adrian A Franke
Unhee Lim
Loïc Le Marchand
Timothy W Randolph
Johanna W Lampe
Meredith A J Hullar
author_sort Gertraud Maskarinec
title The gut microbiome and type 2 diabetes status in the Multiethnic Cohort.
title_short The gut microbiome and type 2 diabetes status in the Multiethnic Cohort.
title_full The gut microbiome and type 2 diabetes status in the Multiethnic Cohort.
title_fullStr The gut microbiome and type 2 diabetes status in the Multiethnic Cohort.
title_full_unstemmed The gut microbiome and type 2 diabetes status in the Multiethnic Cohort.
title_sort gut microbiome and type 2 diabetes status in the multiethnic cohort.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/5267dcdebb2e4c11a87671af2e458496
work_keys_str_mv AT gertraudmaskarinec thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT phyllisraquinio thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT bruceskristal thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT veronicawsetiawan thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT lynnerwilkens thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT adrianafranke thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT unheelim thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT loiclemarchand thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT timothywrandolph thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT johannawlampe thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT meredithajhullar thegutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT gertraudmaskarinec gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT phyllisraquinio gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT bruceskristal gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT veronicawsetiawan gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT lynnerwilkens gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT adrianafranke gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT unheelim gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT loiclemarchand gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT timothywrandolph gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT johannawlampe gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
AT meredithajhullar gutmicrobiomeandtype2diabetesstatusinthemultiethniccohort
_version_ 1718375659263229952